The number of product recalls under the authority of the US Food and Drug Administration (FDA) has increased in quantity and complexity over time. An audit conducted by the Health and Human Services (HHS) Office of the Inspector General (OIG) in 2016 recommended that the FDA develop more efficient and effective processes to handle the volume of food recalls. Opportunities for improvement were identified in FDA's oversight of recall initiation, monitoring of recalls, and the information captured and maintained in FDA's electronic recall data system. A 2020 survey conducted by the Association of Food and Drug Officials also identified the need for enhanced collaboration during recalls of FDA regulated products. Besides an increase in the number of recalls, regulators and industry navigate unique public health challenges to effectively carry out a food recall. Specifically on the regulatory side, recalls cannot be processed and executed efficiently when regulatory partners are not effectively collaborating at the local, state, and federal levels. This can reduce cooperation from industry and, more importantly, puts the public health at risk. To address the issue, the Recall Integration Partnership Project (RIPP) was developed by the Partnership for Food Protection (PFP), a group of dedicated professionals from federal, state, and local governments with roles in protecting the food supply and public health. The initiative created a formal pathway for the development and maintenance of FDA/state stakeholder relationships with an overarching goal of enhanced communication and increased understanding of FDA/state roles and responsibilities during industry recall events of FDA regulated products to leverage appropriate regulatory or enforcement capabilities to protect public health. A downloadable tool kit was created that provides agencies with resources necessary to get started with the RIPP, including a framework for goal setting, discussion topics, and a worksheet for documenting outcomes. The project framework consists of five steps: 1.Pre-project evaluation to establish a baseline; 2.Schedule regular meetings to discuss identified topics; 3.Create points of contact; 4.Document findings; 5.Post project evaluation to determine the effectiveness of the project. To date, ten federal-state partner pairs have completed the project. After completion of the project, 83% of partner pairs indicated that they gained a greater awareness of their partner agency’s responsibilities during industry recalls of FDA regulated product and 40% of partner pairs reported a decrease in duplication of efforts during the highest risk of these recalls. The RIPP is a long-term continuous improvement initiative, and it provides a framework that can be scaled to similar interagency collaborations, to enhance public health protection on a local, national, or global scale.